Title : Cytogenetic guided therapy using blinatumomab and inotuzumab ozogamicin in a patient with relapse/refractory acute lymphoblastic leukemia.

Pub. Date : 2022 Jan 19

PMID : 35043731






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Consequently, she received inotuzumab ozogamicin attributable to 70% expression of CD22. OZOGAMICIN CD22 molecule Homo sapiens